Beta 2-adrenoceptor agonists and thyroid hormones
| Autor: | T L Svendsen, J. P. Kampmann, J E Mølholm Hansen, L. Skovsted |
|---|---|
| Rok vydání: | 1982 |
| Předmět: |
Adult
Male Agonist Drug Thyroid Hormones medicine.medical_specialty medicine.drug_class media_common.quotation_subject Terbutaline Hyperthyroidism chemistry.chemical_compound Internal medicine medicine Humans Pharmacology (medical) Euthyroid Receptor Beta (finance) media_common Pharmacology Triiodothyronine business.industry Adrenergic beta-Agonists Reverse triiodothyronine Endocrinology chemistry Female business Research Article medicine.drug |
| Zdroj: | British Journal of Clinical Pharmacology. 14:447-448 |
| ISSN: | 0306-5251 |
| DOI: | 10.1111/j.1365-2125.1982.tb02006.x |
| Popis: | The potential influence of the selective beta 2-adrenoceptor agonist terbutaline on the serum concentration of the thyroid hormones in humans was studied in 11 healthy euthyroid subjects. Five served as a control group without medication while six received 5 mg terbutaline three times daily for 2 weeks. No significant differences were found between the two groups by measuring the serum concentrations of thyroxine, triiodothyronine, reverse triiodothyronine and resin-triiodothyronine uptake. The use of a beta 2-adrenergic receptor stimulating drug is relatively contraindicated in untreated thyrotoxicosis. This recommendation is based upon a summation of clinical adverse reactions and not due to an effect on the serum concentrations of thyroid hormones. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text